US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alumis Inc.

4.44

-0.0900-1.99%

Post-market: 4.36-0.0800-1.80%17:55 EDT

Volume:769.44K

Turnover:3.37M

Market Cap:462.05M

PE:-1.17

High:4.66

Open:4.53

Low:4.28

Close:4.53

52wk High:13.11

52wk Low:2.76

Shares:104.06M

Float Shares:80.76M

Volume Ratio:0.79

T/O Rate:0.95%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.8055

EPS(LYR):-10.3816

ROE:-66.35%

ROA:-59.84%

PB:0.95

PE(LYR):-0.43

Loading ...

Overview Company News Filings

Alumis Insiders Still US$77k Away From Original Investment Value

Simply Wall St.

Alumis Inc. Set to Present at H.C. Wainwright 27th Annual Global Investment Conference

Calendar of U.S. Earnings Expected in the Week Ahead

Alumis Is Maintained at Overweight by Morgan Stanley

Calendar of U.S. Earnings Expected in the Week Ahead

Alumis Inc reports results for the quarter ended June 30 - Earnings Summary

Alumis Q2 Sales $2.67M Beat $2.00M Estimate

BRIEF-Alumis Q2 Net Income USD 59.321 Million Vs. IBES Estimate USD -103 Million

Alumis Inc - $486.3 Mln in Cash and Securities as of June 30, Expected to Fund Operations Into 2027

THOMSON REUTERS

Alumis - Topline Data From Onward Expected in Early Q1 2026, Lumus Topline Data Expected in Q3 2026

THOMSON REUTERS

Alumis Inc expected to post a loss of $1.38 a share - Earnings Preview

Alumis Inc. Concluded Annual Stockholders Meeting

Wells Fargo Initiates Alumis at Overweight With $17 Price Target

MT Newswires Live

Alumis Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $17

THOMSON REUTERS

Alumis Inc - Topline Readout Expected in Q3 2026

THOMSON REUTERS

Alumis Inc - Completes Patient Enrollment in Global Lumus Phase 2B Trial of Esk-001

THOMSON REUTERS

Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus

Alumis Inc. Files Initial Beneficial Ownership Statement for Sanam Pangali, Chief Legal Officer

Press Release: Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary

BRIEF-Alumis Files For Mixed Shelf Offering Of Up To $400 Mln

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALMS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":4.44,"timestamp":1760126400000,"preClose":4.53,"halted":0,"volume":769435,"hourTrading":{"tag":"盘后","latestPrice":4.36,"preClose":4.44,"latestTime":"17:55 EDT","volume":12143,"amount":53896.474783000005,"timestamp":1760133348147},"delay":0,"floatShares":80756771,"shares":104064302,"eps":-3.805488,"marketStatus":"Post-Mkt","change":-0.09,"latestTime":"10-10 18:38:29 EDT","open":4.53,"high":4.66,"low":4.275,"amount":3366048.4486525,"amplitude":0.084989,"askPrice":4.99,"askSize":100,"bidPrice":4.25,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-3.805488,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1760140800000},"marketStatusCode":4,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":4.53,"preHourTrading":{"tag":"盘前","latestPrice":4.6,"preClose":4.53,"latestTime":"09:24 EDT","volume":27,"amount":123.609996,"timestamp":1760102687227},"postHourTrading":{"tag":"盘后","latestPrice":4.36,"preClose":4.44,"latestTime":"17:55 EDT","volume":12143,"amount":53896.474783000005,"timestamp":1760133348147},"volumeRatio":0.788255,"impliedVol":0.5157,"impliedVolPercentile":0.0156},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":80756771,"roa":"-59.84%","roe":"-66.35%","lyrEps":-10.381567,"volumeRatio":0.788255,"shares":104064302,"dividePrice":0,"high":4.66,"amplitude":0.084989,"preClose":4.53,"low":4.275,"week52Low":2.7601,"pbRate":"0.95","psRate":"23.04","week52High":13.11,"institutionHeld":0,"latestPrice":4.44,"committee":-0.904762,"eps":-3.805488,"divideRate":0,"volume":769435,"delay":0,"ttmEps":-3.805488,"open":4.53,"prevYearClose":7.86,"prevWeekClose":4.02,"prevMonthClose":3.99,"prevQuarterClose":3.99,"fiveDayClose":4.02,"twentyDayClose":4.37,"sixtyDayClose":3.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"ALMS","fiscalQuarterEnding":"2025/06","expectedEps":-1.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-14","symbol":"ALMS","fiscalQuarterEnding":"2025/03","expectedEps":-1.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"ALMS","fiscalQuarterEnding":"2024/09","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1753502400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2025-10-09","current":-1.166736,"percent":0.383901,"low":-4.913756,"twenty":-3.392543,"median":-1.867544,"eighty":-0.80289,"high":-0.443678,"avg":-1.993174,"sd":1.163681,"marketCap":461004857},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295},{"date":"2025-07-03","current":-0.538752,"twenty":-3.462191,"median":-1.878715,"eighty":-0.88573,"marketCap":184978849},{"date":"2025-07-11","current":-0.564105,"twenty":-3.459313,"median":-1.85837,"eighty":-0.848748,"marketCap":193683736},{"date":"2025-07-18","current":-0.556182,"twenty":-3.450679,"median":-1.833144,"eighty":-0.808067,"marketCap":190963459},{"date":"2025-07-25","current":-0.611642,"twenty":-3.444923,"median":-1.819538,"eighty":-0.791425,"marketCap":210005399},{"date":"2025-08-01","current":-0.65601,"twenty":-3.444923,"median":-1.768203,"eighty":-0.766929,"marketCap":225238952},{"date":"2025-08-08","current":-1.301335,"twenty":-3.442045,"median":-1.745417,"eighty":-0.761839,"marketCap":446809517},{"date":"2025-08-15","current":-2.007939,"twenty":-3.439167,"median":-1.743138,"eighty":-0.765537,"marketCap":456842285},{"date":"2025-08-22","current":-2.103991,"twenty":-3.427655,"median":-1.761367,"eighty":-0.766929,"marketCap":478695789},{"date":"2025-08-29","current":-2.14973,"twenty":-3.424777,"median":-1.805264,"eighty":-0.766929,"marketCap":489102219},{"date":"2025-09-05","current":-2.103991,"twenty":-3.415567,"median":-1.826307,"eighty":-0.771366,"marketCap":478695789},{"date":"2025-09-12","current":-1.994217,"twenty":-3.40866,"median":-1.836561,"eighty":-0.773109,"marketCap":453720356},{"date":"2025-09-19","current":-1.9622,"twenty":-3.406179,"median":-1.867544,"eighty":-0.787793,"marketCap":446435855},{"date":"2025-09-26","current":-1.824983,"twenty":-3.405847,"median":-1.875296,"eighty":-0.795863,"marketCap":415216564},{"date":"2025-10-03","current":-1.811262,"twenty":-3.397967,"median":-1.860219,"eighty":-0.799931,"marketCap":412094635},{"date":"2025-10-09","current":-2.026235,"twenty":-3.392543,"median":-1.867544,"eighty":-0.80289,"marketCap":461004857}],"updateTime":1760135909874},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573293179","title":"Alumis Insiders Still US$77k Away From Original Investment Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2573293179","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573293179?lang=en_us&edition=fundamental","pubTime":"2025-10-08 18:07","pubTimestamp":1759918023,"startTime":"0","endTime":"0","summary":"Insiders who bought US$230.3k worth of Alumis Inc. ( NASDAQ:ALMS ) stock in the last year recovered part of their...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/alumis-insiders-still-us77k-away-from-original-investment-va","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/alumis-insiders-still-us77k-away-from-original-investment-va","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2563804476","title":"Alumis Inc. Set to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2563804476","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563804476?lang=en_us&edition=fundamental","pubTime":"2025-08-29 19:00","pubTimestamp":1756465244,"startTime":"0","endTime":"0","summary":"Alumis Inc., a late-stage biopharma company, is set to participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York, NY. The company will deliver a presentation on September 9 at 10:30 am ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via GlobeNewswire  on August 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nNDLc9KGBZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU0314104364.USD","BK4007","BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","ALMS","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD"],"gpt_icon":0},{"id":"2560905684","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2560905684","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560905684?lang=en_us&edition=fundamental","pubTime":"2025-08-18 18:00","pubTimestamp":1755511200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitdeer Tech Gp                                 2Q      (.12)  7:00 AM. ·Palo Alto Ntwrks                                4Q       .89   4:05 PM. ·XP Inc. Class A                                   2Q       .43       AMC. ·Home Depot Inc.                                   2Q      4.72   6:00 AM. ·Jack Henry & Ass.                               4Q      1.57       AMC","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","TOL","ALMS","KC","TGT","WMT","ZTO","DY","BTDR","BLNK","OSIS","BJ","LXEO","CSIQ","ZIM","PALI","WDAY","GDS","WSM","HTHT","CRDL","VNET","ROST","HD","AVNW","GGAL","RVPH","NDSN","COTY","MDT","ADI","TENX","PINC","LZB","ANNX","SLDB","ANRO","LYTS","JHX","VIK","ABEO","SLQT","KEYS","EARN","AS","ALM"],"gpt_icon":1},{"id":"2559914350","title":"Alumis Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2559914350","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559914350?lang=en_us&edition=fundamental","pubTime":"2025-08-15 20:51","pubTimestamp":1755262260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 15, 2025 08:51 ET (12:51 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2559915331","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2559915331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559915331?lang=en_us&edition=fundamental","pubTime":"2025-08-15 18:00","pubTimestamp":1755252000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·BitFuFu Inc. Class A                            2Q       .06       BMO. ·Flowers Foods Inc.                               2Q       .30   7:00 AM. ·Palo Alto Netwrks                               4Q       .89   4:05 PM. ·Home Depot Inc.                                   2Q      4.72   6:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","VIK","YMM","BBW","OCS","ESTC","OSIS","ATAI","SOC","KC","ZM","WALD","ZURA","OVID","KOD","LZB","SPHR","COTY","TOL","VNET","AVNW","GDS","ALC","IVVD","JKHY","LXEO","CRGO","GOGL","FL","CRDL","JHX","HTHT","SLQT","ALM","ANRO","EL","NYXH","FLNG","WMT","ZTO","GGAL","SCSC","XP","CLSD","INTU","FUFU","MZTI"],"gpt_icon":1},{"id":"2559965571","title":"Alumis Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559965571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559965571?lang=en_us&edition=fundamental","pubTime":"2025-08-15 00:19","pubTimestamp":1755188385,"startTime":"0","endTime":"0","summary":"Alumis Inc reports results for the quarter ended June 30 - Earnings SummaryAlumis Inc ALMS.OQ reported a quarterly adjusted loss of $1.68 per share for the quarter ended June 30, higher than the same ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nL8N3U61CK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2559981571","title":"Alumis Q2 Sales $2.67M Beat $2.00M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559981571","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559981571?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:28","pubTimestamp":1755116904,"startTime":"0","endTime":"0","summary":"Alumis (NASDAQ:ALMS) reported quarterly sales of $2.67 million which beat the analyst consensus estimate of $2.00 million by 33.30 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47106946/alumis-q2-sales-2-67m-beat-2-00m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alumis Q2 Sales $2.67M Beat $2.00M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2559989434","title":"BRIEF-Alumis  Q2 Net Income USD 59.321 Million Vs. IBES Estimate USD -103 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989434","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989434?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:05","pubTimestamp":1755115546,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis Q2 Net Income USD 59.321 Million Vs. IBES Estimate USD -103 Million\n\n\nAug 13 (Reuters) - Alumis Q2 income from operations USD -140.539 million vs. IBES estimate USD -99 million.\n\nQ2 operating expenses USD 143.205 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX25E5D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2559989206","title":"Alumis Inc - $486.3 Mln in Cash and Securities as of June 30, Expected to Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989206?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:05","pubTimestamp":1755115501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX25E5D5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2559897829","title":"Alumis - Topline Data From Onward Expected in Early Q1 2026, Lumus Topline Data Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2559897829","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559897829?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:05","pubTimestamp":1755115501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX25E5D5:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2558557056","title":"Alumis Inc  expected to post a loss of $1.38 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2558557056","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558557056?lang=en_us&edition=fundamental","pubTime":"2025-08-09 06:48","pubTimestamp":1754693303,"startTime":"0","endTime":"0","summary":"Alumis Inc  expected to post a loss of $1.38 a share - Earnings Preview Alumis Inc ALMS.OQ ALMS.O is expected to  show a rise in quarterly revenue when it reports  results on August 11 (estimated) for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U03UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2557433901","title":"Alumis Inc. Concluded Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2557433901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557433901?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:07","pubTimestamp":1754338059,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL7dK2Vw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2554388762","title":"Wells Fargo Initiates Alumis at Overweight With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2554388762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554388762?lang=en_us&edition=fundamental","pubTime":"2025-07-25 19:55","pubTimestamp":1753444544,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) has an average rating of buy and mean price target of $19, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and resea","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMS"],"gpt_icon":0},{"id":"2554766471","title":"Alumis Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2554766471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554766471?lang=en_us&edition=fundamental","pubTime":"2025-07-25 18:31","pubTimestamp":1753439487,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nAZN49JCJW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2553842207","title":"Alumis Inc - Topline Readout Expected in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2553842207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553842207?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:35","pubTimestamp":1753356931,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL25V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2553220782","title":"Alumis Inc - Completes Patient Enrollment in Global Lumus Phase 2B Trial of Esk-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2553220782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553220782?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:35","pubTimestamp":1753356931,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL25V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2553880847","title":"Alumis Completes Patient Enrollment in the Global LUMUS Phase 2b Trial of ESK-001, a Next-Generation Oral TYK2 Inhibitor for the Treatment of Systemic Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=2553880847","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553880847?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:30","pubTimestamp":1753356600,"startTime":"0","endTime":"0","summary":"-Topline Readout Expected in Q3 2026- SOUTH SAN FRANCISCO, Calif., July  24, 2025  (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/24/3120949/0/en/Alumis-Completes-Patient-Enrollment-in-the-Global-LUMUS-Phase-2b-Trial-of-ESK-001-a-Next-Generation-Oral-TYK2-Inhibitor-for-the-Treatment-of-Systemic-Lupus-Erythematosus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS","IFN","BK4077","SLE","BK4523"],"gpt_icon":0},{"id":"2551135499","title":"Alumis Inc. Files Initial Beneficial Ownership Statement for Sanam Pangali, Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2551135499","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551135499?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:15","pubTimestamp":1752524154,"startTime":"0","endTime":"0","summary":"Alumis Inc. has filed an initial statement of beneficial ownership, identifying Sanam Pangali as the beneficial owner. Pangali holds the position of Chief Legal Officer at the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL7H2jXy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2551359181","title":"Press Release: Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2551359181","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551359181?lang=en_us&edition=fundamental","pubTime":"2025-07-15 04:05","pubTimestamp":1752523500,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., July 14, 2025  -- Alumis Inc. , a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced the promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary. Sanam most recently served as Senior Vice President, Legal of Alumis. In her new role, she will lead all legal and compliance functions, including corporate governance, intellectual property, and strategic advisory on key decisions and transactions. Sanam succeeds Sara Klein, following her retirement from the company.Alumis is a late-stage biopharma company developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, Alumis is developing a pipeline of oral tyrosine kinase 2 inhibitors, consisting of ESK-001 for the treatment of systemic immu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2548382847","title":"BRIEF-Alumis Files For Mixed Shelf Offering Of Up To $400 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2548382847","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548382847?lang=en_us&edition=fundamental","pubTime":"2025-07-04 02:52","pubTimestamp":1751568773,"startTime":"0","endTime":"0","summary":"BRIEF-Alumis Files For Mixed Shelf Offering Of Up To $400 MlnJuly 3 (Reuters) - Alumis Inc ALMS.O:ALUMIS INC FILES FOR MIXED SHELF OFFERING OF UP TO $400 MILLION- SEC FILINGSource text: [ID:n0001104659-25-065745]Further company coverage: ALMS.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nFWN3T00F1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}]}}